Evidence map›Paper›PMID 34802777›Full record

ArticleAddictive behaviors2022

Validation of the tobacco, alcohol, prescription medication, and other substance use (TAPS) tool with the WHO alcohol, smoking, and substance Involvement screening test (ASSIST).

Gentry Carter, Ziji Yu, M Aryana Bryan, Jennifer L Brown, T Winhusen, Gerald Cochran

Registry-linked trialOpen access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Addictive behaviors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05569915 (Project QueST 2023), which is not on this map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05569915 nacompletednot on this mapstarted 2023, after this paper: background citation

Project QueST 2023: Queer Survivors of Trauma

TypeinterventionalSponsorSyracuse UniversityRan2023 to 2024Enrolled131ConditionsStress Disorders, Post-Traumatic, Drinking HeavyArmsTrauma Expressive Writing, Stigma Expressive Writing, Control
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Gentry CarterUniversity of Utah, Department of Internal Medicine, USA.
Ziji YuUniversity of Utah, Department of Internal Medicine, USA.
M Aryana BryanUniversity of Utah, Department of Internal Medicine, USA.
Jennifer L BrownUniversity of Cincinnati, Department of Psychiatry and Behavioral Neuroscience, USA; University of Cincinnati, Department of Psychology, USA; Center for Addiction Research, University of Cincinnati, USA.
T WinhusenUniversity of Cincinnati, Department of Psychiatry and Behavioral Neuroscience, USA; Center for Addiction Research, University of Cincinnati, USA.
Gerald CochranUniversity of Utah, Department of Internal Medicine, USA.
University of Utah · USUniversity of Cincinnati · US

Funding

The Ohio Valley Node of the Clinical Trials Network (CTN-0153)UG1DA013732 · NIDA · UNIVERSITY OF CINCINNATI · PI T John WINHUSEN · 2015 to 2026
$42.5M
Greater Intermountain Node (CTN-0151)UG1DA049444 · NIDA · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Gerald T. Cochran, Adam Joseph Gordon · 2019 to 2026
$16.8M
NIDA NIH HHS UG1 DA013732NIDA NIH HHS UG1 DA049444
6 · The paper itself

Abstract

introductionCommunity pharmacies are emerging as a valuable setting to identify patients with substance use. Few tools have been specially validated to screen patients in these settings, particularly among those prescribed opioid medications. The goal of this study was to validate the performance of the Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) tool in community pharmacy settings compared to a reference-standard substance use assessment.

methodsParticipants were recruited while receiving opioid medications (not solely buprenorphine) from 19 pharmacies from a large national chain in Ohio and Indiana. Adults who were not involved in the criminal justice system or receiving cancer treatment were invited to participate in a one-time, cross-sectional, self-administered, health survey which included the TAPS tool. Substance use risks calculated from the TAPS tool were compared with the reference standard, World Health Organization Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) using confusion matrices. We calculated Areas Under the Curve (AUC) of Receiver Operating Characteristics Curves (ROC) to evaluate the TAPS tool's validity.

resultsThe TAPS tool showed fair or better discrimination between moderate-risk use and high-risk use for tobacco, alcohol, and prescription opioids (AUCs: 0.75-0.97 and fair or better discrimination between low-risk and moderate-risk use in five of eight subscales, including tobacco, alcohol, marijuana, stimulants, and heroin (AUCs: 0.70-0.92).

conclusionThe TAPS tool detected clinically relevant problem substance use in several drug classes and likely would be a valuable assessment for screening illicit drug use among community pharmacy patients prescribed opioid medications.

Indexed as

Substance-Related DisordersAdultCross-Sectional StudiesHumansMass ScreeningNicotianaPrescriptionsPrimary Health CareSmokingWorld Health OrganizationCommunity pharmacy interventionOpioid useScreeningSubstance use disordersUnhealthy substance use

Identifiers

PMID34802777
PMCPMC8712403
OpenAlexW3213364696

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.